AR
Aryzta AG
ARZTY · OTC
$4.72 +0.00% (+$0.00)
1M -7.63%
Market Cap 1.08B €
P/E Ratio 10.03x
Div. Yield -
ROE 22.66%
Bulios Fair Price
$5.75
21.8% upside
Current Price
$4.72
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ARZTY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
100 /100
Cheap P/FCF 6.54x
P/S 0.51x
P/B 1.96x
Growth
80 /100
Growing FCF growth 12.28%
Book val. growth 15.99%
Rev. growth 6.74%
Profitability
50 /100
Moderate Net margin 5.05%
Op. margin 7.76%
FCF margin 7.74%
Quality
74 /100
Excellent ROE 22.66%
ROA 5.71%
Asset turnover 1.13x
Debt
33 /100
High Current ratio 0.58x
Int. coverage 3.53x
Net debt/EBITDA 2.20x
Stability
50 /100
Moderate Rev. volatility 12.25%
EPS volatility 2,225.67%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARZTY
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Urs Jordi
Employees
7,654
Headquarters
Schlieren